Related Experiment Video

Updated: Jun 3, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Cardiac stem cell therapy. Registered trials and a pilot study in patients with dilated cardiomyopathy

C Nesselmann1, A Kaminski, G Steinhoff

  • 1Department of Cardiac Surgery, University of Rostock, Schillingallee 35, 18057, Rostock, Deutschland. Catharina.nesselmann@med.uni-rostock.de

Herz
|March 23, 2011
PubMed

Insights

Cardiac stem cell therapy research is diverse, making impact assessment challenging. This study summarizes registered trials and presents new data on CD133+ stem cell administration in mitral valve surgery patients.

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Cardiac stem cell therapy has seen extensive preclinical and clinical research over the last decade.
  • A significant challenge in the field is the high diversity of stem cell populations and evaluation methods used, leading to uncertain conclusions.
  • Understanding the precise impact of stem cell administration in cardiac repair remains an active area of investigation.

Purpose of the Study:

  • To summarize registered studies in cardiac stem cell therapy.
  • To highlight the specific aims of various cardiac stem cell therapy research initiatives.
  • To present preliminary data on the intramyocardial administration of CD133+ stem cells in patients undergoing mitral valve surgery.

Main Methods:

  • Systematic review and summarization of registered clinical trials in cardiac stem cell therapy.
  • Analysis of study aims and methodologies across diverse trials.
  • Presentation of preliminary data from a specific patient cohort receiving additional intramyocardial CD133+ stem cells during mitral valve surgery.

Main Results:

  • The review highlights the heterogeneity in stem cell types and assessment techniques employed in cardiac stem cell therapy research.
  • Uncertainty persists regarding the definitive impact and optimal application of stem cell therapy in cardiac conditions.
  • Preliminary findings on the safety and potential efficacy of CD133+ stem cell administration in the context of mitral valve surgery are provided.

Conclusions:

  • The diversity in cardiac stem cell therapy research necessitates standardized approaches for clearer impact assessment.
  • Further research is required to elucidate the mechanisms and optimize the use of stem cells for cardiac repair.
  • The presented preliminary data offers insights into a specific application of CD133+ stem cells in cardiovascular surgery.

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes08:47

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Published on: December 16, 2022

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...